Abstract:Vascular dementia is the second-most cause of dementia, characterized by cerebral infarcts, white matter lesions, myelin loss and often amyloid angiopathy. Hence, vascular damage is a critical cause of neuronal loss and synaptic disintegration. Abnormal neuroinflammation, autophagy and apoptosis are the prerequisite factors for endothelial and neuronal cell damage. This leads to the onset and progression of cerebrovascular disorders and cognitive dysfunction. The innate immune cells, pattern recognition receptors, Toll-like receptor-4 and related inflammatory mechanisms disrupt cerebrovascular integrity via glial activation and increased pro-inflammatory interleukins and TNFα. Inflammasome polymorphisms and multi-faceted neuro-immune interactions further integrate systemic and central inflammatory pathways, which induce vascular tissue injury and neurodegeneration. Specifically, chronic cerebral hypoperfusion disrupts the self-cannibalization mechanism of autophagy via altered expression of autophagy-specific proteins, Beclin-1, LC3 and P62. The deregulated autophagy pathway causes neuronal loss, hippocampal shrinkage, and ultimate loss in synaptic plasticity. The vascular dementia models typically exhibit downregulated anti-apoptotic Bcl-2 and upregulated pro-apoptotic Bax, cleaved caspase-3, and cleaved-PARP levels in the brain, for which modulated p38 MAPK and JNK phosphorylation pathways play a vital role. Endoplasmic stress-induced apoptosis, calcium overload and glutamate excitotoxicity in combination with ASK1-MAPK signaling mechanism also contribute to the cerebrovascular pathology. Vascular injury reduces neurological scores and increases the infarct volume, DNA damage and neuronal apoptosis in ischemia/reperfusion injury. Additionally, synergistic and additive interactions between inflammasome, autophagy and apoptotic signaling pathways augment symptoms of vascular neurodegeneration. Overall, the current review enlightens the key risk factors and underlying mechanism triggering vascular dementia. The review additionally informs the challenges associated while treating vascular dysfunction, and highlights the need for targeted drugs for reducing cerebrovascular damage.

Roles of vascular risk factors in the pathogenesis of dementia

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Vascular Contributions to Healthy Aging and Dementia

Causal cardiovascular risk factors for dementia – insights from observational and genetic studies

Vascular cognitive impairment and dementia: Mechanisms, treatment, and future directions

Cardiovascular Disease and Dementia: Exploring Intersections, Risks, and Therapeutic Challenges

Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers

Vascular contributions to Alzheimer's disease

Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles

Vascular Dementia: From Pathobiology to Emerging Perspectives

Inflammation, apoptosis and autophagy as critical players in vascular dementia

A Comprehensive Review of Modifiable Cardiovascular Risk Factors and Genetic Influences in Dementia Prevention

Cardiovascular disease, associated risk factors, and risk of dementia: An umbrella review of meta-analyses

Vascular Risk Factors and Brain Health in Aging: Insights from a Community-Based Cohort Study

A systematic review of the association between dementia risk factors and cerebrovascular reactivity

Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention

The Pathobiology of Vascular Dementia

Epidemiological Insights, Risk Factors and Prevention Pathways

Global epidemiology of dementia: Alzheimer's and vascular types

Pathogenesis, Rehabilitation Assessment, Treatment Status, and Research Progress of Vascular Dementia

The impact of cerebrovascular aging on vascular cognitive impairment and dementia